MRES (Institute of Biomedical Research) ROIC %: -4.28% (As of Dec. 2010)

What is Institute of Biomedical Research ROIC %?

Institute of Biomedical Research MRES ROIC % is -4.28% as of Dec. 2010.

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. Institute of Biomedical Research's annualized return on invested capital (ROIC %) for the quarter that ended in Dec. 2010 was -4.28%.

As of today (2026-06-26), Institute of Biomedical Research's WACC % is 0.00%. Institute of Biomedical Research's ROIC % is 0.00% (calculated using TTM income statement data). Institute of Biomedical Research earns returns that do not match up to its cost of capital. It will destroy value as it grows.

Institute of Biomedical Research (OTCPK:MRES) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Institute of Biomedical Research's WACC % is 0.00%. Institute of Biomedical Research's ROIC % is 0.00% (calculated using TTM income statement data). Institute of Biomedical Research earns returns that do not match up to its cost of capital. It will destroy value as it grows.

Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Institute of Biomedical Research ROIC % Related Terms

Institute of Biomedical Research ROIC % Historical Data

* Premium members only.

The historical data trend for Institute of Biomedical Research's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Institute of Biomedical Research ROIC % Chart

Institute of Biomedical Research Annual Data

Trend

Dec03

Dec04

Mar06

Mar07

Mar08

Mar09

Mar10

ROIC %

Get a 7-Day Free Trial

-2.68

-576.76

-5,554.17

-268.55

-74.86

Institute of Biomedical Research Quarterly Data
	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10
ROIC %	Get a 7-Day Free Trial															-560.00	-167.81	-15,376.67	-6.42	-4.28

MRES vs HSTC, NTRR, VITIF: ROIC % Comparison

For the Biotechnology subindustry, Institute of Biomedical Research's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Institute of Biomedical Research ROIC % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Institute of Biomedical Research's ROIC % distribution charts can be found below:

* The bar in red indicates where Institute of Biomedical Research's ROIC % falls into.

Save Embed

Institute of Biomedical Research ROIC % Calculation

Institute of Biomedical Research's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Mar. 2010 is calculated as:

	ROIC % (A: Mar. 2010 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (A: Mar. 2009 )	+	Invested Capital (A: Mar. 2010 ))	/ count )
=	-0.262 * ( 1 - 0% )	/	( (0.222	+	0.478)	/ 2 )
=	-0.262	/	0.35
=	-74.86 %

where

	Invested Capital		(A: Mar. 2009 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0.078	-	0.003	-	( 0	-	max(0, 0.149	-	0.002	+	0	))
=	0.222

	Invested Capital		(A: Mar. 2010 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0.076	-	0.02	-	( 0	-	max(0, 0.422	-	0	+	0	))
=	0.478

Institute of Biomedical Research's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Dec. 2010 is calculated as:

	ROIC % (Q: Dec. 2010 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Sep. 2010 )	+	Invested Capital (Q: Dec. 2010 ))	/ count )
=	-0.072 * ( 1 - 0% )	/	( (2.25	+	1.116)	/ 2 )
=	-0.072	/	1.683
=	-4.28 %

where

	Invested Capital		(Q: Sep. 2010 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0.668	-	0.072	-	( 0	-	max(0, 1.654	-	0	+	0	))
=	2.25

	Invested Capital		(Q: Dec. 2010 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0.655	-	0	-	( 0	-	max(0, 0.461	-	0	+	0	))
=	1.116

Note: The Operating Income data used here is four times the quarterly (Dec. 2010) data. The tax rate is limited to between 0% and 100%.

Frequently Asked Questions Learn more about ROIC % →

What does a ROIC % of -4.28% mean?

Institute of Biomedical Research (MRES) has a ROIC % of -4.28% as of Dec. 2010. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on Institute of Biomedical Research and its competitors.

Is Institute of Biomedical Research's ROIC % too high?

Institute of Biomedical Research's current ROIC % is -4.28%.

How does Institute of Biomedical Research's ROIC % compare to HSTC and NTRR?

Institute of Biomedical Research's ROIC % of -4.28% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROIC % for a Biotechnology company?

A good ROIC % depends on the Biotechnology industry context. However, ROIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROIC % mean?

A high ROIC % can signal that a stock is expensive relative to its fundamentals. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on Institute of Biomedical Research and its competitors. Institute of Biomedical Research's current ROIC % is -4.28%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Institute of Biomedical Research stock overvalued right now?

Institute of Biomedical Research (MRES) has a current ROIC % of -4.28%. The current ROIC % is -4.28%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROIC % calculated?

ROIC % is calculated from a company's financial statements. For Institute of Biomedical Research (MRES), the current ROIC % is -4.28% as of Dec. 2010. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Institute of Biomedical Research Business Description

Industry Healthcare Biotechnology

Comparable Companies HSTC NTRR VITIF TLOG NSPX ERGO OPLI GLAG FPMI ADYNF ENTB CAPS BTHE GOVX LCAR IMUC CTBO GNBT ICOTF TIKRF

Address Dubai Science Park, 13th Floor, South Tower, Dubai, ARE, 416452

Website https://www.m2bio.co

Institute of Biomedical Research Corp is a biomedical research and development company. The company is focused on alternative plant-based food and medicine and mental health therapeutic research. The company uses brand name M2Bio Sciences engaged in deploying artificial intelligence, science and medicine, clinical research, and emerging technologies.